Literature DB >> 2833831

Adenoid cystic carcinoma of the lacrimal gland, is there a cure?

J W Henderson1.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 2833831      PMCID: PMC1298781     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  3 in total

1.  Combined therapeutic approach to malignant lacrimal gland tumors.

Authors:  R M Byers; R G Berkeley; M Luna; R H Jesse
Journal:  Am J Ophthalmol       Date:  1975-01       Impact factor: 5.258

2.  A comparative ultrastructural study of the normal lacrimal gland and its epithelial tumors.

Authors:  T Iwamoto; F A Jakobiec
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

3.  Adenoid cystic carcinoma of the lacrimal gland: the clinical significance of a basaloid histologic pattern.

Authors:  J W Gamel; R L Font
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

  3 in total
  5 in total

1.  Orbital exenteration: surgical and reconstructive strategies.

Authors:  C Mohr; J Esser
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-05       Impact factor: 3.117

2.  Evolution of Care of Orbital Tumors with Radiation Therapy.

Authors:  Myrsini Ioakeim-Ioannidou; Shannon M MacDonald
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-24

3.  Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse
Journal:  Trans Am Ophthalmol Soc       Date:  2005

4.  Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.

Authors:  David T Tse; Pasquale W Benedetto; Brian C Tse; William J Feuer
Journal:  Am J Ophthalmol       Date:  2022-04-02       Impact factor: 5.488

5.  Primary malignant neoplasms of the lacrimal gland.

Authors:  J E Wright; G E Rose; A Garner
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.